Manifestations of Helicobacter pylori infection outside the digestive system
Abstract
Helicobacter pylori (H. pylori) infection leads to various diseases such as gastric and duodenal ulcers, chronic gastritis and malignant diseases, including MALT lymphoma and stomach cancer. To date, various factors of pathogenicity and virulence of the H. pylori bacterium have been studied. The interaction of infection with host cells leads to the induction of inflammatory responses through the release of cytokines, activation of apoptosis or proliferation, which leads to inflammation and dysfunction of the epithelial barrier. This process can facilitate the movement of H. pylori virulence factors and inflammatory mediators into the bloodstream and promote or enhance the development of a systemic inflammatory response and the possible clinical effects of H. pylori infections outside the stomach. The purpose of this review is to clarify the available data on the relationship of H. pylori infection with diseases of the cardiovascular, nervous, endocrine systems, autoimmune diseases, and some other pathologies outside the digestive system.
About the Authors
A. S. Sarsenbaevа
South-Urals State Medical University
Russian Federation
Russian Federation
Chelyabinsk
E. V. Domracheva
Medical Center “Gastroenterological Practice Ufimtseva K.A.”
Russian Federation
Russian Federation
Chelyabinsk
References
1. Blaser M. J., Atherton J. C. Helicobacter pylori persistence: biology and disease // J. Clin. Invest. 2004. Т. 113, № 3. С. 321–333.
2. Peek R. M., Crabtree J. E. Helicobacter infection and gastric neoplasia // J. Pathol. 2006. Т. 208, № 2. С. 233–248.
3. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors // Nat. Rev. Gastroenterol. Hepatol. 2010. Т. 7, № 11. С. 629–641.
4. Posselt G., Backert S., Wessler S. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis // Cell Commun. Signal. 2013. Т. 11. С. 77.
5. Suzuki N., Murata-Kamiya N., Yanagiya K. et al. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein // Sci. Rep. 2015. Т. 5. С. 10024.
6. Machado J. C., Figueiredo C., Canedo P. et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma // Gastroenterology. 2003. Т. 125, № 2. С. 364–371.
7. Ilver D., Arnqvist A., Ogren J. et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging // Science. 1998. Т. 279, № 5349. С. 373–377.
8. Mahdavi J., Sondén B., Hurtig M. et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation // Science. 2002. Т. 297, № 5581. С. 573–578.
9. Styer C. M., Hansen L. M., Cooke C. L. et al. Expression of the BabA adhesin during experimental infection with Helicobacter pylori // Infect. Immun. 2010. Т. 78, № 4. С. 1593–1600.
10. Pai R., Wyle F. A., Cover T. L. et al. Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells // Am. J. Pathol. 1998. Т. 152, № 6. С. 1617–1624.
11. Seto K., Hayashi-Kuwabara Y., Yoneta T. et al. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by the EGF receptor in HeLa cells // FEBS Lett. 1998. Т. 431, № 3. С. 347–350.
12. Lytton S. D., Fischer W., Nagel W. et al. Production of ammonium by Helicobacter pylori mediates occludin processing and disruption of tight junctions in Caco-2 cells // Microbiology (Reading). 2005. Т. 151, ч. 10. С. 3267–3276.
13. Yahiro K., Wada A., Nakayama M. et al. Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor // J. Biol. Chem. 2003. Т. 278, № 21. С. 19183–19189.
14. Yahiro K., Satoh M., Nakano M. et al. Low-density lipoprotein receptor-related protein-1 (LRP1) mediates autophagy and apoptosis caused by Helicobacter pylori VacA // J. Biol. Chem. 2012. Т. 287, № 37. С. 31104–31115.
15. Cover T. L., Blanke S. R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality // Nat. Rev. Microbiol. 2005. Т. 3, № 4. С. 320–332.
16. Covacci A., Censini S., Bugnoli M. et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer // Proc. Natl. Acad. Sci. U S A. 1993. Т. 90, № 12. С. 5791–5795.
17. Tummuru M. K., Cover T. L., Blaser M. J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production // Infect. Immun. 1993. Т. 61, № 5. С. 1799–1809.
18. Crabtree J. E., Covacci A., Farmery S. M. et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype // J. Clin. Pathol. 1995. Т. 48, № 1. С. 41–45.
19. Huang J. Q., Zheng G. F., Sumanac K. et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer // Gastroenterology. 2003. Т. 125, № 6. С. 1636–1644.
20. Backert S., Clyne M., Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori // Cell Commun. Signal. 2011. Т. 9. С. 28.
21. Higashi H., Tsutsumi R., Muto S. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein // Science. 2002. Т. 295, № 5555. С. 683–686.
22. Suzuki M., Mimuro H., Kiga K. et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation // Cell Host Microbe. 2009. Т. 5, № 1. С. 23–34.
23. Peek R. M., Moss S. F., Tham K. T. et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis // J. Natl. Cancer Inst. 1997. Т. 89, № 12. С. 863–868.
24. Paziak-Domańska B., Chmiela M., Jarosińska A. et al. Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections // Cell. Immunol. 2000. Т. 202, № 2. С. 136–139.
25. Censini S., Lange C., Xiang Z. et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors // Proc. Natl. Acad. Sci. U S A. 1996. Т. 93, № 25. С. 14648–14653.
26. Backert S., Kwok T., Schmid M. et al. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry // Proteomics. 2005. Т. 5, № 5. С. 1331–1345.
27. Olofsson A., Vallström A., Petzold K. et al. Biochemical and functional characterization of Helicobacter pylori vesicles // Mol. Microbiol. 2010. Т. 77, № 6. С. 1539–1555.
28. Parker H., Chitcholtan K., Hampton M. B. et al. Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells // Infect. Immun. 2010. Т. 78, № 12. С. 5054–5061.
29. Fiocca R., Necchi V., Sommi P. et al. Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium // J. Pathol. 1999. Т. 188, № 2. С. 220–226.
30. Heczko U., Smith V. C., Mark Meloche R. et al. Characteristics of Helicobacter pylori attachment to human primary antral epithelial cells // Microbes Infect. 2000. Т. 2, № 14. С. 1669–1676.
31. Olofsson A., Nygård Skalman L., Obi I. et al. Uptake of Helicobacter pylori vesicles is facilitated by clathrin-dependent and clathrin-independent endocytic pathways // MBio. 2014. Т. 5, № 3. С. e00979–e00914.
32. Shimoda A., Ueda K., Nishiumi S. et al. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA // Sci. Rep. 2016. Т. 6. С. 18346.
33. Akada J., Okuda M., Hiramoto N. et al. Proteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array // PLoS One. 2014. Т. 9, № 8. С. e104611.
34. Arnold I. C., Hitzler I., Engler D. et al. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia // J. Immunol. 2011. Т. 186, № 11. С. 6165–6172.
35. Shiota S., Matsunari O., Watada M. et al. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in eastAsian countries // Future Microbiol. 2010. Т. 5, № 12. С. 1885–1893.
36. Tummuru M. K., Sharma S. A., Blaser M. J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells // Mol. Microbiol. 1995. Т. 18, № 5. С. 867–876.
37. Yamaoka Y., Kita M., Kodama T. et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains // Gut. 1997. Т. 41, № 4. С. 442–451.
38. Smith M. F., Mitchell A., Li G. et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells // J. Biol. Chem. 2003. Т. 278, № 35. С. 32552–32560.
39. Grebowska A., Moran A. P., Matusiak A. et al. Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS) — possible modulation of the innate immune response to these bacteria // Pol. J. Microbiol. 2008. Т. 57, № 3. С. 185–192.
40. Grebowska A., Moran A. P., Bielanski W. et al. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures // J. Physiol. Pharmacol. 2010. Т. 61, № 4. С. 437–442.
41. Rudnicka K., Miszczyk E., Matusiak A. et al. Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity // Innate Immun. 2015. Т. 21, № 2. С. 127–139.
42. Suzuki M., Mori M., Miyayama A. et al. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication // J. Clin. Gastroenterol. 1997. Т. 25, прил. 1. С. S222–S228.
43. Bruewer M., Luegering A., Kucharzik T. et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms // J. Immunol. 2003. Т. 171, № 11. С. 6164–6172.
44. Wroblewski L. E., Shen L., Ogden S. et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation // Gastroenterology. 2009. Т. 136, № 1. С. 236–246.
45. Tan H. J., Goh K. L. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review // J. Dig. Dis. 2012. Т. 13, № 7. С. 342–349.
46. Ram M., Barzilai O., Shapira Y. et al. Helicobacter pylori serology in autoimmune diseases — fact or fiction? // Clin. Chem. Lab. Med. 2013. Т. 51, № 5. С. 1075–1082.
47. Uemura N., Okamoto S., Yamamoto S. et al. Helicobacter pylori infection and the development of gastric cancer // N. Engl. J. Med. 2001. Т. 345, № 11. С. 784–789.
48. Jackson L., Britton J., Lewis S. A. et al. A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation // Helicobacter. 2009. Т. 14, № 5. С. 108–113.
49. Amedei A., Bergman M. P., Appelmelk B. J. et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity // J. Exp. Med. 2003. Т. 198, № 8. С. 1147–1156.
50. Yamanishi S., Iizumi T., Watanabe E. et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease // Infect. Immun. 2006. Т. 74, № 1. С. 248–256.
51. Aragona P., Magazzù G., Macchia G. et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome // J. Rheumatol. 1999. Т. 26, № 6. С. 1306–1311.
52. Goo M. J., Ki M. R., Lee H. R. et al. Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori // Eur. J. Gastroenterol. Hepatol. 2008. Т. 20, № 10. С. 1045–1048.
53. Ge Z., Hiratsuka K., Taylor D. E. Nucleotide sequence and mutational analysis indicate that two Helicobacter pylori genes encode a P-type ATPase and a cation-binding protein associated with copper transport // Mol. Microbiol. 1995. Т. 15, № 1. С. 97–106.
54. Melchers K., Weitzenegger T., Buhmann A. et al. Cloning and membrane topology of a P type ATPase from Helicobacter pylori // J. Biol. Chem. 1996. Т. 271, № 1. С. 446–457.
55. Cover T. L., Tummuru M. K., Cao P. et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains // J. Biol. Chem. 1994. Т. 269, № 14. С. 10566–10573.
56. Uibo R., Vorobjova T., Metsküla K. et al. Association of Helicobacter pylori and gastric autoimmunity: a population-based study // FEMS Immunol. Med. Microbiol. 1995. Т. 11, № 1. С. 65–68.
57. Kansau I., Guillain F., Thiberge J. M. et al. Nickel binding and immunological properties of the C-terminal domain of the Helicobacter pylori GroES homologue (HspA) // Mol. Microbiol. 1996. Т. 22, № 5. С. 1013–1023.
58. Guarneri F., Guarneri C., Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? // J. Cell. Mol. Med. 2005. Т. 9, № 3. С. 741–744.
59. Chmiela M., Gonciarz W. Molecular mimicry in Helicobacter pylori infections // World J. Gastroenterol. 2017. Т. 23, № 22. С. 3964–3977.
60. Tsang K. W., Lam W. K., Chan K. N. et al. Helicobacter pylori sero-prevalence in asthma // Respir. Med. 2000. Т. 94, № 8. С. 756–759.
61. Wang Q., Yu C., Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis // Helicobacter. 2013. Т. 18, № 1. С. 41–53.
62. Chen C., Xun P., Tsinovoi C. et al. Accumulated evidence on Helicobacter pylori infection and the risk of asthma: A meta-analysis // Ann. Allergy Asthma Immunol. 2017. Т. 119, № 2. С. 137–145.e2.
63. Lankarani K. B., Honarvar B., Athari S. S. The Mechanisms Underlying Helicobacter Pylori-Mediated Protection against Allergic Asthma // Tanaffos. 2017. Т. 16, № 4. С. 251–259.
64. D'Elios M. M., Codolo G., Amedei A. et al. Helicobacter pylori, asthma and allergy // FEMS Immunol. Med. Microbiol. 2009. Т. 56, № 1. С. 1–8.
65. Freire de Melo F., Rocha A. M., Rocha G. A. et al. A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children // Microbes Infect. 2012. Т. 14, № 4. С. 341–347.
66. Fouda E. M., Kamel T. B., Nabih E. S. et al. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity // Allergol. Immunopathol. (Madr.). 2018. Т. 46, № 1. С. 76–81.
67. Okada H., Kuhn C., Feillet H. et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update // Clin. Exp. Immunol. 2010. Т. 160, № 1. С. 1–9.
68. Chen Y., Blaser M. J. Inverse associations of Helicobacter pylori with asthma and allergy // Arch. Intern. Med. 2007. Т. 167, № 8. С. 821–827.
69. Miftahussurur M., Nusi I. A., Graham D. Y. et al. Helicobacter, Hygiene, Atopy, and Asthma // Front. Microbiol. 2017. Т. 8. С. 1034.
70. Takahashi T., Yujiri T., Shinohara K. et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura // Br. J. Haematol. 2004. Т. 124, № 1. С. 91–96.
71. Kodama M., Kitadai Y., Ito M. et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura // Helicobacter. 2007. Т. 12, № 1. С. 36–42.
72. Gasbarrini A., Franceschi F., Tartaglione R. et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori // Lancet. 1998. Т. 352, № 9131. С. 878.
73. Rocha A. M., Souza C., Melo F. F. et al. Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication // Br. J. Haematol. 2015. Т. 168, № 3. С. 421–428.
74. Kim B. J., Kim H. S., Jang H. J. et al. Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials // Gastroenterol. Res. Pract. 2018. Т. 2018. С. 6090878.
75. Ozelo M. C., Colella M. P., de Paula E. V. et al. Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira — 2018 // Hematol. Transfus. Cell Ther. 2018. Т. 40, № 1. С. 50–74.
76. Wang F., Liu J., Lv Z. Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants // Scand. J. Infect. Dis. 2013. Т. 45, № 12. С. 930–938.
77. Kim H. J., Kim Y. J., Lee H. J. et al. Systematic review and meta-analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria // Helicobacter. 2019. Т. 24, № 6. С. e12661.
78. Gu H., Li L., Gu M. et al. Association between Helicobacter pylori Infection and Chronic Urticaria: A Meta-Analysis // Gastroenterol. Res. Pract. 2015. Т. 2015. С. 486974.
79. Behrangi E., Mansouri P., Agah S. et al. Association between Helicobacter Pylori Infection and Alopecia Areata: A Study in Iranian Population // Middle East J. Dig. Dis. 2017. Т. 9, № 2. С. 107–110.
80. Yang S., Xia Y. P., Luo X. Y. et al. Exosomal CagA derived from Helicobacter pylori-infected gastric epithelial cells induces macrophage foam cell formation and promotes atherosclerosis // J. Mol. Cell. Cardiol. 2019. Т. 135. С. 40–51.
81. Sung K. C., Rhee E. J., Ryu S. H. et al. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults // Int. J. Cardiol. 2005. Т. 102, № 3. С. 411–417.
82. Iwai N., Okuda T., Oka K. et al. Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study // PLoS One. 2019. Т. 14, № 8. С. e0221349.
83. Liu J., Wang F., Shi S. Helicobacter pylori Infection Increase the Risk of Myocardial Infarction: A Meta-Analysis of 26 Studies Involving more than 20,000 Participants // Helicobacter. 2015. Т. 20, № 3. С. 176–183.
84. Tabata N., Sueta D., Akasaka T. et al. Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction // PLoS One. 2016. Т. 11, № 11. С. e0166240.
85. Wan Z., Hu L., Hu M. et al. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults // J. Hum. Hypertens. 2018. Т. 32, № 2. С. 158–164.
86. Ramji D. P., Davies T. S. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets // Cytokine Growth Factor Rev. 2015. Т. 26, № 6. С. 673–685.
87. Kotsis V., Stabouli S., Papakatsika S. et al. Mechanisms of obesity-induced hypertension // Hypertens. Res. 2010. Т. 33, № 5. С. 386–393.
88. Sun J., Rangan P., Bhat S. S. et al. A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies // Helicobacter. 2016. Т. 21, № 1. С. 11–23.
89. Tamura A., Fujioka T., Nasu M. Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography // Am. J. Gastroenterol. 2002. Т. 97, № 4. С. 861–866.
90. Kutluana U., Kilciler A. G. Is there a possible relationship between gastric intestinal metaplasia and systemic arterial stiffness? // Rev. Esp. Enferm. Dig. 2019. Т. 111, № 7. С. 500–506.
91. Szlachcic A., Sliwowski Z., Karczewska E. et al. Helicobacter pylori and its eradication in rosacea // J. Physiol. Pharmacol. 1999. Т. 50, № 5. С. 777–786.
92. Saleh P., Naghavi-Behzad M., Herizchi H. et al. Effects of Helicobacter pylori treatment on rosacea: A single-arm clinical trial study // J. Dermatol. 2017. Т. 44, № 9. С. 1033–1037.
93. Yang X. Relationship between Helicobacter pylori and Rosacea: review and discussion // BMC Infect. Dis. 2018. Т. 18, № 1. С. 318.
94. Gravina A., Federico A., Ruocco E. et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea // United European Gastroenterol. J. 2015. Т. 3, № 1. С. 17–24.
95. Jørgensen A. R., Egeberg A., Gideonsson R. et al. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis // J. Eur. Acad. Dermatol. Venereol. 2017. Т. 31, № 12. С. 2010–2015.
96. Yu M., Zhang R., Ni P. et al. Helicobacter pylori Infection and Psoriasis: A Systematic Review and Meta-Analysis // Medicina (Kaunas). 2019. Т. 55, № 10. С. 645.
97. Chen J., Xing Y., Zhao L. et al. The Association between Helicobacter pylori Infection and Glycated Hemoglobin A in Diabetes: A Meta-Analysis // J. Diabetes Res. 2019. Т. 2019. С. 3705264.
98. Wellen K. E., Hotamisligil G. S. Inflammation, stress, and diabetes // J. Clin. Invest. 2005. Т. 115, № 5. С. 1111–1119.
99. Li W., Minohara M., Su J. J. et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population // J. Neuroimmunol. 2007. Т. 184, № 1-2. С. 227–231.
100. Jaruvongvanich V., Sanguankeo A., Jaruvongvanich S. et al. Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis // Mult. Scler. Relat. Disord. 2016. Т. 7. С. 92–97.
101. Yao G., Wang P., Luo X. D. et al. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis // Neurosci. Lett. 2016. Т. 620. С. 1–7.
102. Strachan D. P. Hay fever, hygiene, and household size // BMJ. 1989. Т. 299, № 6710. С. 1259–1260.
103. Salama N. R., Hartung M. L., Müller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori // Nat. Rev. Microbiol. 2013. Т. 11, № 6. С. 385–399.
104. Cossu D., Masala S., Cocco E. et al. Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia? // Mult. Scler. 2012. Т. 18, № 8. С. 1181–1184.
105. Efthymiou G., Dardiotis E., Liaskos C. et al. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis // Sci. Rep. 2017. Т. 7. С. 7929.
106. Lane C. A., Hardy J., Schott J. M. Alzheimer's disease // Eur. J. Neurol. 2018. Т. 25, № 1. С. 59–70.
107. Shindler-Itskovitch T., Ravona-Springer R., Leibovitz A. et al. A Systematic Review and Meta-Analysis of the Association between Helicobacterpylori Infection and Dementia // J. Alzheimers Dis. 2016. Т. 52, № 4. С. 1431–1442.
108. Fu P., Gao M., Yung K. K. L. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis // ACS Chem. Neurosci. 2020. Т. 11, № 3. С. 395–405.
109. Wang X. L., Zeng J., Yang Y. et al. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β // J. Alzheimers Dis. 2015. Т. 43, № 1. С. 153–165.
110. Kountouras J., Tsolaki F., Tsolaki M. et al. Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults // Dis. Esophagus. 2016. Т. 29, № 7. С. 842.
111. Doulberis M., Kotronis G., Thomann R. et al. Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far? // Helicobacter. 2018. Т. 23, № 1.
112. Carabotti M., Scirocco A., Maselli M. A. et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems // Ann. Gastroenterol. 2015. Т. 28, № 2. С. 203–209.
113. Kountouras J., Zavos C., Polyzos S. A. et al. The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems // Ann. Gastroenterol. 2015. Т. 28, № 4. С. 506.
114. Deretzi G., Kountouras J., Polyzos S. A. et al. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases // Curr. Mol. Med. 2011. Т. 11, № 8. С. 696–707.
115. Deretzi G., Kountouras J., Grigoriadis N. et al. From the "little brain" gastrointestinal infection to the “big brain” neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis // Med. Hypotheses. 2009. Т. 73, № 5. С. 781–787.
116. Gavalas E., Kountouras J., Deretzi G. et al. Helicobacter pylori and multiple sclerosis // J. Neuroimmunol. 2007. Т. 188, № 1-2. С. 187–189.
117. Kountouras J., Tsolaki M., Gavalas E. et al. Relationship between Helicobacter pylori infection and Alzheimer disease // Neurology. 2006. Т. 66, № 6. С. 938–940.
118. Wang H., Liu X., Tan C. et al. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies // Brain Behav. 2020. Т. 10, № 3. С. e01549.
119. Dardiotis E., Tsouris Z., Mentis A. A. et al. H. pylori and Parkinson's disease: Meta-analyses including clinical severity // Clin. Neurol. Neurosurg. 2018. Т. 175. С. 16–24.
120. Caputi V., Giron M. C. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease // Int. J. Mol. Sci. 2018. Т. 19, № 6. С. 1689.
121. Dardiotis E., Sokratous M., Tsouris Z. et al. Association between Helicobacter pylori infection and Guillain-Barré Syndrome: A meta-analysis // Eur. J. Clin. Invest. 2020. Т. 50, № 5. С. e13218.
122. Mindel J. S., Rosenberg E. W. Is Helicobacter pylori of interest to ophthalmologists? // Ophthalmology. 1997. Т. 104, № 11. С. 1729–1730.
123. Baim A. D., Movahedan A., Farooq A. V. et al. The microbiome and ophthalmic disease // Exp. Biol. Med. (Maywood). 2019. Т. 244, № 6. С. 419–429.
124. Saccà S. C., Vagge A., Pulliero A. et al. Helicobacter pylori infection and eye diseases: a systematic review // Medicine (Baltimore). 2014. Т. 93, № 28. С. e216.
125. Zeng J., Liu H., Liu X. et al. The Relationship Between Helicobacter pylori Infection and Open-Angle Glaucoma: A Meta-Analysis // Invest. Ophthalmol. Vis. Sci. 2015. Т. 56, № 9. С. 5238–5245.
126. Kountouras J., Mylopoulos N., Chatzopoulos D. et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma // Arch. Intern. Med. 2002. Т. 162, № 11. С. 1237–1244.
127. Daković Z., Vesić S., Vuković J. et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series // Acta Dermatovenerol. Alp. Pannonica Adriat. 2007. Т. 16, № 2. С. 83–86.
128. Bagheri M., Rashe Z., Ahoor M. H. et al. Prevalence of Helicobacter pylori Infection in Patients with Central Serous Chorioretinopathy: A Review // Med. Hypothesis Discov. Innov. Ophthalmol. 2017. Т. 6, № 4. С. 118–124.
129. Saccà S. C., Pascotto A., Venturino G. M. et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis // Invest. Ophthalmol. Vis. Sci. 2006. Т. 47, № 2. С. 501–508.
130. Cotticelli L., Borrelli M., D'Alessio A. C. et al. Central serous chorioretinopathy and Helicobacter pylori // Eur. J. Ophthalmol. 2006. Т. 16, № 2. С. 274–278.
131. Saki N., Jahani M., Samarbaf A. et al. Correlation Between Tympanosclerosis and Helicobacter pylori // Jundishapur J. Microbiol. 2015. Т. 8, № 10. С. e16069.
132. Saki N., Nikakhlagh S., Modaress D. Incidence of oitis media with effusion in first grade students of ahwaz school // Sic. Med. J. 2005. Т. 4, № 3. С. 211–215.
133. Saki N., Nikakhlagh S., Ahmadi K. Comparison of PCR assay and culture for detecting bacteria in middle ear fluid of children with otitis media with effusion // Int. Adv. Otol. 2009. Т. 5, № 1. С. 31.
134. White D. R., Heavner S. B., Hardy S. M. et al. Gastroesophageal reflux and eustachian tube dysfunction in an animal model // Laryngoscope. 2002. Т. 112, № 6. С. 955–961.
135. Heavner S. B., Hardy S. M., White D. R. et al. Transient inflammation and dysfunction of the eustachian tube secondary to multiple exposures of simulated gastroesophageal refluxant // Ann. Otol. Rhinol. Laryngol. 2001. Т. 110, № 10. С. 928–934.
136. Megale S. R., Scanavini A. B., Andrade E. C. et al. Gastroesophageal reflux disease: its importance in ear, nose, and throat practice // Int. J. Pediatr. Otorhinolaryngol. 2006. Т. 70, № 1. С. 81–88.
137. Saki N., Samarbaf Zadeh A. R., Sheikhpour Jonaky R. et al. The prevalence rate of Helicobacter pylori infection in, chronic otitis media with effusion patients // Jundishapur J. Microbiol. 2014. Т. 7, № 3. С. e16069.
138. Ozcan C., Vayisoglu Y., Otag F. et al. Does Helicobacter pylori have a role in the development of chronic otitis media with effusion? A preliminary study // J. Otolaryngol. Head Neck Surg. 2009. Т. 38, № 5. С. 526–531.
139. Wu Y., Yin S., Zhu H. et al. [Tympanosclerosis incidence among patients with chronic suppurative otitis media] // Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006. Т. 20, № 22. С. 1016–1017.
140. Iriz A., Eryilmaz A., Gocer C. et al. Could Helicobacter pylori play a role in the aetiopathogenesis of tympanosclerosis? // J. Laryngol. Otol. 2011. Т. 125, № 11. С. 1121–1124.
141. Asaoka D., Nagahara A., Shimada Y. et al. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? // Ther. Clin. Risk Manag. 2015. Т. 11. С. 381–391.
142. Lin S. C., Koo M., Tsai K. W. Association between Helicobacter pylori infection and risk of osteoporosis in elderly Taiwanese women with upper gastrointestinal diseases: a retrospective patient record review // Gastroenterol. Res. Pract. 2014. Т. 2014. С. 814756.
143. Kakehasi A. M., Mendes C. M., Coelho L. G. et al. The presence of Helicobacter pylori in postmenopausal women is not a factor to the decrease of bone mineral density // Arq. Gastroenterol. 2007. Т. 44, № 3. С. 266–270.
144. Fotouk-Kiai M., Hoseini S. R., Meftah N. et al. Relationship between Helicobacter pylori infection (HP) and bone mineral density (BMD) in elderly people // Caspian J. Intern. Med. 2015. Т. 6, № 2. С. 62–66.
145. Moss S. F., Legon S., Davies J. et al. Cytokine gene expression in Helicobacter pylori associated antral gastritis // Gut. 1994. Т. 35, № 11. С. 1567–1570.
146. Yamaoka Y., Kita M., Kodama T. et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains // Gut. 1997. Т. 41, № 4. С. 442–451.
147. Rokkas T., Pistiolas D., Sechopoulos P. et al. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis // Helicobacter. 2007. Т. 12, прил. 2. С. 32–38.
148. Toyokawa T., Suwaki K., Miyake Y. et al. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study // J. Gastroenterol. Hepatol. 2010. Т. 25, № 3. С. 544–547.
149. Iijima K., Sekine H., Koike T. et al. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria // Aliment. Pharmacol. Ther. 2004. Т. 19, № 11. С. 1181–1188.
150. Tilg H., Moschen A. R., Kaser A. et al. Gut, inflammation and osteoporosis: basic and clinical concepts // Gut. 2008. Т. 57, № 5. С. 684–694.
Review
For citations:
Sarsenbaevа A.S., Domracheva E.V. Manifestations of Helicobacter pylori infection outside the digestive system. Title in english. 2021;16(4):29-42. (In Russ.)
Views:
97
Email this article 